What are you looking for today?

Hodgson, Kirsty, Orozco-Moreno, Margarita, Goode, Emily Archer, Fisher, Matthew, Garnham, Rebecca, Beatson, Richard, Turner, Helen, Livermore, Karen, Zhou, Yuhan, Wilson, Laura, Visser, Eline A, Pijnenborg, Johan FA, Eerden, Nienke, Moons, Sam J, Rossing, Emiel, Hysenaj, Gerald, Krishna, Rashi, Peng, Ziqian, Nangkana, Kyla Putri, Schmidt, Edward N, Duxfield, Adam, Dennis, Ella P, Heer, Rakesh, Lawson, Michelle A, Macauley, Matthew, Elliott, David J, Büll, Christian, Scott, Emma, Boltje, Thomas J, Drake, Richard R, Wang, Ning and Munkley, Jennifer (2024) Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone. eBioMedicine, 104 (105163). ISSN 2352-3964

Document

Abstract

Abstract

Background

Bone metastasis is a common consequence of advanced prostate cancer. Bisphosphonates can be used to manage symptoms, but there are currently no curative treatments available. Altered tumour cell glycosylation is a hallmark of cancer and is an important driver of a malignant phenotype. In prostate cancer, the sialyltransferase ST6GAL1 is upregulated, and studies show ST6GAL1-mediated aberrant sialylation of N-glycans promotes prostate tumour growth and disease progression.

Methods

Here, we monitor ST6GAL1 in tumour and serum samples from men with aggressive prostate cancer and using in vitro and in vivo models we investigate the role of ST6GAL1 in prostate cancer bone metastasis.

Findings

ST6GAL1 is upregulated in patients with prostate cancer with tumours that have spread to the bone and can promote prostate cancer bone metastasis in vivo. The mechanisms involved are multi-faceted and involve modification of the pre-metastatic niche towards bone resorption to promote the vicious cycle, promoting the development of M2 like macrophages, and the regulation of immunosuppressive sialoglycans. Furthermore, using syngeneic mouse models, we show that inhibiting sialylation can block the spread of prostate tumours to bone.

Interpretation

Our study identifies an important role for ST6GAL1 and α2-6 sialylated N-glycans in prostate cancer bone metastasis, provides proof-of-concept data to show that inhibiting sialylation can suppress the spread of prostate tumours to bone, and highlights sialic acid blockade as an exciting new strategy to develop new therapies for patients with advanced prostate cancer.

Item Type: Article
Depositing User: Rebecca Garnham
URI: https://sure.sunderland.ac.uk/id/eprint/17673

Further Details

More Information

Depositing User

Identifiers

Item ID
17673
Identification Number
ISSN
2352-3964

Users with ORCIDS

Catalogue record

Date Deposited
29 May 2024 08:12
Last Modified
26 Nov 2025 09:09

Contributors

Author
Kirsty Hodgson
Author
Margarita Orozco-Moreno
Author
Emily Archer Goode
Author
Matthew Fisher
Author
Rebecca Garnham
Author
Richard Beatson
Author
Helen Turner
Author
Karen Livermore
Author
Yuhan Zhou
Author
Laura Wilson
Author
Eline A Visser
Author
Johan FA Pijnenborg
Author
Nienke Eerden
Author
Sam J Moons
Author
Emiel Rossing
Author
Gerald Hysenaj
Author
Rashi Krishna
Author
Ziqian Peng
Author
Kyla Putri Nangkana
Author
Edward N Schmidt
Author
Adam Duxfield
Author
Ella P Dennis
Author
Rakesh Heer
Author
Michelle A Lawson
Author
Matthew Macauley
Author
David J Elliott
Author
Christian Büll
Author
Emma Scott
Author
Thomas J Boltje
Author
Richard R Drake
Author
Ning Wang
Author
Jennifer Munkley

University Divisions

Subjects

Actions (login required)

View Item (Repository Staff Only)

Downloads per month over past year